Cargando…

Glucocorticoids suppress Wnt16 expression in osteoblasts in vitro and in vivo

Glucocorticoid-induced osteoporosis is a frequent complication of systemic glucocorticoid (GC) therapy and mainly characterized by suppressed osteoblast activity. Wnt16 derived from osteogenic cells is a key determinant of bone mass. Here, we assessed whether GC suppress bone formation via inhibitin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hildebrandt, Susanne, Baschant, Ulrike, Thiele, Sylvia, Tuckermann, Jan, Hofbauer, Lorenz C., Rauner, Martina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992207/ https://www.ncbi.nlm.nih.gov/pubmed/29880826 http://dx.doi.org/10.1038/s41598-018-26300-z

Ejemplares similares

Author Correction: Glucocorticoids suppress Wnt16 expression in osteoblasts in vitro and in vivo
por: Hildebrandt, Susanne, et al.
Publicado: (2020)

Bad to the Bone: The Effects of Therapeutic Glucocorticoids on Osteoblasts and Osteocytes
por: Gado, Manuel, et al.
Publicado: (2022)

Erythropoietin inhibits osteoblast function in myelodysplastic syndromes via the canonical Wnt pathway
por: Balaian, Ekaterina, et al.
Publicado: (2018)

Regulation of sclerostin in glucocorticoid-induced osteoporosis (GIO) in mice and humans
por: Thiele, Sylvia, et al.
Publicado: (2019)

Mice lacking DKK1 in T cells exhibit high bone mass and are protected from estrogen-deficiency-induced bone loss
por: Lehmann, Juliane, et al.
Publicado: (2021)

Dicer ablation in osteoblasts by Runx2 driven cre-loxP recombination affects bone integrity, but not glucocorticoid-induced suppression of bone formation
por: Liu, Peng, et al.
Publicado: (2016)

Glucocorticoid receptor in stromal cells is essential for glucocorticoid-mediated suppression of inflammation in arthritis
por: Koenen, Mascha, et al.
Publicado: (2018)

Effects of adipocyte-specific Dkk1 deletion on bone homeostasis and obesity-induced bone loss in male mice
por: Daamouch, Souad, et al.
Publicado: (2023)

Transferrin receptor 2 deficiency promotes macrophage polarization and inflammatory arthritis
por: Ledesma-Colunga, Maria G., et al.
Publicado: (2023)

Role of osteogenic Dickkopf-1 in bone remodeling and bone healing in mice with type I diabetes mellitus
por: Hildebrandt, Nick, et al.
Publicado: (2021)

Wnt16 signaling promotes osteoblast differentiation of periosteal derived cells in vitro and in vivo
por: Jin, Ying, et al.
Publicado: (2020)

Loss of Dkk-1 in Osteocytes Mitigates Alveolar Bone Loss in Mice With Periodontitis
por: Goes, Paula, et al.
Publicado: (2019)

Artificial Extracellular Matrices with Oversulfated Glycosaminoglycan Derivatives Promote the Differentiation of Osteoblast-Precursor Cells and Premature Osteoblasts
por: Hempel, Ute, et al.
Publicado: (2014)

SAT-586 Cold-Acclimation Prevents the Onset of Glucocorticoid-Induced Adipose Dysfunction in Male Mice
por: Gado, Manuel M, et al.
Publicado: (2020)

Editorial: Glucocorticoid and bone: Friend or foe
por: Baschant, Ulrike, et al.
Publicado: (2022)

Vanadate prevents glucocorticoid-induced apoptosis of osteoblasts in vitro and osteocytes in vivo
por: Conradie, M M, et al.
Publicado: (2007)

Rodent Models of Spondyloarthritis Have Decreased White and Bone Marrow Adipose Tissue Depots
por: Furesi, Giulia, et al.
Publicado: (2021)

High stroma‐derived WNT5A is an indicator for low‐risk prostate cancer
por: Kisel, Wadim, et al.
Publicado: (2021)

p38 MAPK regulates the Wnt inhibitor Dickkopf-1 in osteotropic prostate cancer cells
por: Browne, A J, et al.
Publicado: (2016)

Epo/EpoR signaling in osteoprogenitor cells is essential for bone homeostasis and Epo-induced bone loss
por: Rauner, Martina, et al.
Publicado: (2021)

Role of WNT5A receptors FZD5 and RYK in prostate cancer cells
por: Thiele, Stefanie, et al.
Publicado: (2018)

RF21 | PSAT78 The beta3-Adrenergic Receptor as a Target for the Prevention of Glucocorticoid-induced Adipose Tissue Dysfunction in Rodents
por: Gado, Manuel, et al.
Publicado: (2022)

Exosomal miRNAs from Prostate Cancer Impair Osteoblast Function in Mice
por: Furesi, Giulia, et al.
Publicado: (2022)

The Bone Morphogenetic Protein Pathway: The Osteoclastic Perspective
por: Lademann, Franziska, et al.
Publicado: (2020)

Deconstructing cellular senescence in bone and beyond
por: Hofbauer, Lorenz C., et al.
Publicado: (2023)

Targeting syndecan-1 in breast cancer inhibits osteoclast functions through up-regulation of osteoprotegerin
por: Benad-Mehner, Peggy, et al.
Publicado: (2013)

Transferrin receptor 2 controls bone mass and pathological bone formation via BMP and Wnt signaling
por: Rauner, Martina, et al.
Publicado: (2019)

Increased pore size of scaffolds improves coating efficiency with sulfated hyaluronan and mineralization capacity of osteoblasts
por: Krieghoff, Jan, et al.
Publicado: (2019)

MicroRNA and Diabetic Bone Disease
por: Daamouch, Souad, et al.
Publicado: (2022)

WNT16 elevation induced cell senescence of osteoblasts in ankylosing spondylitis
por: Jo, Sungsin, et al.
Publicado: (2021)

When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis
por: Hayes, Kaleen N., et al.
Publicado: (2021)

Corrigendum: When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis
por: Hayes, Kaleen N., et al.
Publicado: (2022)

Contributions of Dickkopf‐1 to Obesity‐Induced Bone Loss and Marrow Adiposity
por: Colditz, Juliane, et al.
Publicado: (2020)

Loss of menin in osteoblast lineage affects osteocyte–osteoclast crosstalk causing osteoporosis
por: Liu, Peng, et al.
Publicado: (2017)

Low Bone Turnover Due to Hypothyroidism or Anti-Resorptive Treatment Does Not Affect Whole-Body Glucose Homeostasis in Male Mice
por: Lademann, Franziska, et al.
Publicado: (2022)

Luspatercept mitigates bone loss driven by myelodysplastic neoplasms and estrogen-deficiency in mice
por: Weidner, Heike, et al.
Publicado: (2022)

Induction of 3-hydroxy-3-methylglutaryl-CoA reductase mediates statin resistance in breast cancer cells
por: Göbel, Andy, et al.
Publicado: (2019)

Update on the impact of type 2 diabetes mellitus on bone metabolism and material properties
por: Picke, Ann-Kristin, et al.
Publicado: (2019)

Skeletal endocrinology: where evolutionary advantage meets disease
por: Jaschke, Nikolai, et al.
Publicado: (2021)

Irisin and Bone in Sickness and in Health: A Narrative Review of the Literature
por: Tsourdi, Elena, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6j00fg3blhitgcerdj0p5rp79e